Toboroz
Head of Bed After Ischemic Stroke Thrombectomy (HoBIT)
NCT07367633· Population Health Research Institute· Forrás
Contact: Mythili Velma
Meghívásos bevonás
Implementation of Acute Heart Failure Checklist
NCT07727304· Ottawa Hospital Research Institute· Forrás
Toboroz
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044· 2. fázis· Eli Lilly and Company· Forrás
Contact: Anas Eddin (principal investigator)
Toboroz
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
NCT06592924· 3. fázis· Canadian Cancer Trials Group· Forrás
Contact: Eoghan R. Malone (principal investigator)
Toboroz
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
NCT06081894· 3. fázis· Cytokinetics· Forrás
Toboroz
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120· Weill Medical College of Cornell University· Forrás
Contact: Bindu Bittira, MD
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
NCT05451004· 3. fázis· Canadian Cancer Trials Group· Forrás
Contact: Mirko Manojlovic Kolarski (principal investigator)
Fut, nem toboroz
Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study
NCT05543720· University Health Network, Toronto· Forrás
Fut, nem toboroz
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
NCT05556512· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
NCT04093167· 2/3. fázis· Canadian Cancer Trials Group· Forrás
Fut, nem toboroz
Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer
NCT03784755· Canadian Cancer Trials Group· Forrás
Fut, nem toboroz
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
NCT03768570· 2. fázis· Canadian Cancer Trials Group· Forrás
Fut, nem toboroz
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
NCT03914612· 3. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
NCT03536312· Ottawa Heart Institute Research Corporation· Forrás
Contact: Rony Atoui, MD (principal investigator)
Fut, nem toboroz
Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC
NCT03410615· 2. fázis· Canadian Cancer Trials Group· Forrás
Fut, nem toboroz
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
NCT03057106· 2. fázis· Canadian Cancer Trials Group· Forrás
Toboroz
Duration of Anti-PD-1 Therapy in Metastatic Melanoma
NCT02821013· 3. fázis· Canadian Cancer Trials Group· Forrás
Contact: Lacey Pitre
Fut, nem toboroz
Breast Cancer WEight Loss Study (BWEL Study)
NCT02750826· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Fut, nem toboroz
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
NCT02488967· 3. fázis· NRG Oncology· Forrás
Fut, nem toboroz
Economic Analysis of Alliance A041202 CLL Study
NCT02414022· Canadian Cancer Trials Group· Forrás
Fut, nem toboroz
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
NCT01886872· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
NCT01274338· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
NCT01220583· 2. fázis· Radiation Therapy Oncology Group· Forrás
Fut, nem toboroz
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
NCT00956007· 3. fázis· Radiation Therapy Oncology Group· Forrás